Aileron Therapeutics Inc (ALRN)
3.20
-0.01
(-0.31%)
USD |
NASDAQ |
May 31, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
Aileron Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.096M |
| September 30, 2023 | 0.542M |
| June 30, 2023 | 8.50M |
| March 31, 2023 | 7.25M |
| December 31, 2022 | 4.764M |
| September 30, 2022 | 4.182M |
| June 30, 2022 | 5.864M |
| March 31, 2022 | 11.65M |
| December 31, 2021 | 2.251M |
| September 30, 2021 | 4.089M |
| June 30, 2021 | -4.798M |
| March 31, 2021 | -37.46M |
| December 31, 2020 | -0.357M |
| September 30, 2020 | -4.529M |
| June 30, 2020 | 0.239M |
| March 31, 2020 | 11.06M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.764M |
| September 30, 2019 | 3.737M |
| June 30, 2019 | -19.29M |
| March 31, 2019 | 7.973M |
| December 31, 2018 | 8.305M |
| September 30, 2018 | 1.404M |
| June 30, 2018 | 12.58M |
| March 31, 2018 | 2.40M |
| December 31, 2017 | 4.517M |
| September 30, 2017 | -41.44M |
| June 30, 2017 | 5.309M |
| March 31, 2017 | -7.303M |
| December 31, 2016 | 1.484M |
| September 30, 2016 | 4.537M |
| June 30, 2016 | 4.346M |
| March 31, 2016 | -10.39M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-37.46M
Minimum
Mar 2021
11.65M
Maximum
Mar 2022
0.1181M
Average
2.994M
Median
Cash from Investing (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 20.81M |
| INVO Bioscience Inc | -0.0241M |
| Bio-Path Holdings Inc | -- |
| SINTX Technologies Inc | -0.173M |
| Sensus Healthcare Inc | -0.233M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.271M |
| Free Cash Flow | -20.42M |
| Free Cash Flow Per Share (Quarterly) | -0.6349 |
| Free Cash Flow Yield | -115.2% |